preliminary data obtained in the ambit of anturan reinfarction italian study ( aris ) show that , in postmyocardial infarction , reduced platelet survival time occurred in hyperbetalipoproteinemic patients treated with placebo , but not in the group of patients treated with sulfinpyrazone ( interaction between treatment and lipemic level is at p approximately equal to 0.1 ) .
C0591099
anturan
C0038742
sulfinpyrazone